PRELUDE CAPITAL MANAGEMENT, LLC - AGEX THERAPEUTICS INC ownership

AGEX THERAPEUTICS INC's ticker is AGE and the CUSIP is 00848H108. A total of 49 filers reported holding AGEX THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AGEX THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$3,0003,6520.00%
Other shareholders
AGEX THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 346,805$1,379,0001.31%
BROADWOOD CAPITAL INC 2,997,156$8,961,0001.26%
Price Capital Management, Inc. 70,122$210,0000.29%
Prescott General Partners LLC 185,185$554,0000.02%
Destination Wealth Management 34,703$104,0000.01%
STATE OF WISCONSIN INVESTMENT BOARD 472,239$1,412,0000.01%
Riggs Asset Managment Co. Inc. 1,160$3,0000.00%
AXA S.A. 121,258$363,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 24,070$72,0000.00%
Banco de Sabadell, S.A 2,000$6,0000.00%
View complete list of AGEX THERAPEUTICS INC shareholders